Uct943, a next-generation plasmodium falciparum pi4k inhibitor preclinical candidate for the treatment of malaria

  1. Brunschwig, C.
  2. Lawrence, N.
  3. Taylor, D.
  4. Abay, E.
  5. Njoroge, M.
  6. Basarab, G.S.
  7. Le Manach, C.
  8. Paquet, T.
  9. Cabrera, D.G.
  10. Nchinda, A.T.
  11. De Kock, C.
  12. Wiesner, L.
  13. Denti, P.
  14. Waterson, D.
  15. Blasco, B.
  16. Leroy, D.
  17. Witty, M.J.
  18. Donini, C.
  19. Duffy, J.
  20. Wittlin, S.
  21. White, K.L.
  22. Charman, S.A.
  23. Jiménez-Díaz, M.B.
  24. Angulo-Barturen, I.
  25. Herreros, E.
  26. Gamo, F.J.
  27. Rochford, R.
  28. Mancama, D.
  29. Coetzer, T.L.
  30. Van der Watt, M.E.
  31. Reader, J.
  32. Birkholtz, L.-M.
  33. Marsh, K.C.
  34. Solapure, S.M.
  35. Burke, J.E.
  36. McPhail, J.A.
  37. Vanaerschot, M.
  38. Fidock, D.A.
  39. Fish, P.V.
  40. Siegl, P.
  41. Smith, D.A.
  42. Wirjanata, G.
  43. Noviyanti, R.
  44. Price, R.N.
  45. Marfurt, J.
  46. Silue, K.D.
  47. Street, L.J.
  48. Chibaleb, K.
  49. Show all authors +
Journal:
Antimicrobial Agents and Chemotherapy

ISSN: 1098-6596 0066-4804

Year of publication: 2018

Volume: 62

Issue: 9

Type: Article

DOI: 10.1128/AAC.00012-18 GOOGLE SCHOLAR lock_openOpen access editor